Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to evaluate the effect of mindfulness-based cognitive therapy (MBCT) on physical symptoms attributed to chemical exposures, psychological distress, illness worry, quality of life, and illness perceptions in patients suffering from multiple chemical sensitivity (MCS). Furthermore, a secondary objective is to evaluate whether a possible symptom reduction is mediated by an increased level of mindfulness.

The primary hypothesis is that the self-reported severity of MCS symptoms and the degree to which chemical exposures causes symptoms and the impact on daily life will be significantly improved in the MBCT treatment group as compared to the control group.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01240395
Study type Interventional
Source The Danish Research Centre for Chemical Sensitivities
Contact
Status Completed
Phase N/A
Start date September 2011
Completion date May 2013

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04935307 - Central Processing of Odour Stimuli in Patients With Functional Somatic Disorder or MCS Compared to Healthy Controls N/A
Completed NCT00810329 - Proteomics of Cerebrospinal Fluid in Chronic Fatigue Syndrome N/A
Completed NCT01834781 - Pulsed Electromagnetic Fields for Multiple Chemical Sensitivity N/A